Anti-SARS-CoV-2 antibody-containing plasma improves outcome in patients with hematologic or solid cancer and severe COVID-19: a randomized clinical trial - Denkinger, CM; Janssen, M; Schäkel, U (Nat Cancer, 2023)
et al.